Media ReleasesNext Science

View All Next Science News

Next Science - XPERIENCE study findings published

Publication of knee study showing potential anti-inflammatory benefit for XPERIENCE

Next Science Limited (ASX:NXS) (“Next Science” or “the Company”) today announces the publication of a pilot study which demonstrates the utility of XPERIENCE in mitigating inflammation following a Total Knee Arthroplasty (TKA).

Next Science is a medical technology company focused on commercialising its proprietary XBIO suite of products to reduce the impact of biofilm-based infections in human health.

On 9 August 2023, Next Science announced that Dr Andrew Wickline MD had released the findings of a pilot study on VuMedi which showed a potential anti-inflammatory benefit for XPERIENCE, Next Science’s advanced surgical irrigation product.

For more information, download the atttched PDF.

Download this document

Subscribe to our Daily Newsletter?

Would you like to receive our daily news to your inbox?